Economic Implications of Attention-Deficit Hyperactivity Disorder for Healthcare Systems

Author： Leibson C.L.   Kirsten Hall Long  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.17, 2003-01, pp. : 1239-1262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder: Implications for Research and Treatment

By Lepping Peter  

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 721-728

Adis International

Access to resources Recommend Favorite

Substance Abuse in Patients with Attention-Deficit Hyperactivity Disorder: Therapeutic Implications

By Schubiner Howard  

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 643-655

Adis International

Access to resources Recommend Favorite

Progress and Promise of Attention-Deficit Hyperactivity Disorder Pharmacogenetics

By Froehlich Tanya E.   McGough James J.   Stein Mark A.  

CNS Drugs, Vol. 24, Iss. 2, 2010-02 ,pp. : 99-117

Adis International

Access to resources Recommend Favorite

Drug Therapy for Adults with Attention-Deficit Hyperactivity Disorder

By Wilens T.E.  

Drugs, Vol. 63, Iss. 22, 2003-01 ,pp. : 2395-2411

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of Attention-Deficit Hyperactivity Disorder in Adolescents

By Childress Ann C.  

Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. : 309-325

Adis International

Access to resources Recommend Favorite